Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

NCI’s precision medicine initiatives

Dr Shakun Malik - National Cancer Institute, USA
NCI’s precision medicine initiatives ( Dr Shakun Malik - National Cancer Institute, USA )
5 Oct 2016

Immunotherapy in NSCLC

Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA
Immunotherapy in NSCLC ( Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA )
5 Oct 2016

Immunotherapy in SCLC

Prof Dean Fennell - University of Leicester, Leicester, UK
Immunotherapy in SCLC ( Prof Dean Fennell - University of Leicester, Leicester, UK )
5 Oct 2016

Omics, early detection and novel therapies: Epigenetic studies

Dr Adele Murrell - University of Bath, Bath, UK
Omics, early detection and novel therapies: Epigenetic studies ( Dr Adele Murrell - University of Bath, Bath, UK )
5 Oct 2016

We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK
We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK )
5 Oct 2016

Using PDL1 and other biomarkers in patient selection for immunology: Q & A

Dr O'Brien and Prof McVie
Using PDL1 and other biomarkers in patient selection for immunology: Q & A ( Dr O'Brien and Prof McVie )
5 Oct 2016

We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Prof Gordon McVie - King's College London, London, UK
We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Prof Gordon McVie - King's College London, London, UK )
5 Oct 2016

How do cancer registries operate in the UK?

Dr Jem Rashbass - Public Health England, UK
How do cancer registries operate in the UK? ( Dr Jem Rashbass - Public Health England, UK )
30 Sep 2016

Hope, hype, misinformation and clinical evidence

Prof Michael Brada - University of Liverpool, Liverpool, UK
Hope, hype, misinformation and clinical evidence ( Prof Michael Brada - University of Liverpool, Liverpool, UK )
29 Sep 2016

A model-based selection approach to identify suitable indications for proton therapy

Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands
A model-based selection approach to identify suitable indications for proton therapy ( Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands )
27 Sep 2016

IBCD 2016: Patient access and regulatory challenges

Dr Denis Lacombe - EORTC Director General
IBCD 2016: Patient access and regulatory challenges ( Dr Denis Lacombe - EORTC Director General )
26 Sep 2016

Taking complex genomic analysis into practice

Dr Philip Beer - Sanger Institute, Hinxton, UK
Taking complex genomic analysis into practice ( Dr Philip Beer - Sanger Institute, Hinxton, UK )
26 Sep 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation